APDN | tickerfilter.com

Fundamental analysis

25%

Profitability 0%

Dept financing 15%

Liquidity 75%

Performance 40%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-0.05%

1 Month

-48.10%

3 Months

402.10%

6 Months

171.71%

1 Year

-77.62%

2 Year

-95.67%

Key data

Stock price

$0.86

P/E Ratio

0.00

DAY RANGE

$0.84 - $0.87

EPS

-$6.23

52 WEEK RANGE

$0.05 - $4.75

52 WEEK CHANGE

-$78.46

MARKET CAP

10.668 M

YIELD

N/A

SHARES OUTSTANDING

10.299 M

DIVIDEND

$0.00

EX-DIVIDEND DATE

03-14-2025

NEXT EARNINGS DATE

05-09-2025

BETA

5.52

PUBLIC FLOAT

AVERAGE 10 VOLUME

$755,143

AVERAGE 30 VOLUME

$1,451,216

Company detail

CEO: James A. Hayward
Region: US
Website: adnas.com
Employees: 70
IPO year: 2003

Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts.

APDN - APPLIED DNA SCIENCES INC